SIGIRR and cancer: Therefore, it is not surprising that IL-1R8 can act as a tumor suppressor in models of cancer strongly dependent on inflammation, while having a tumor promoting effect by fine-tuning inflammation and avoiding detection and eradication by the immune system in other tumor types.